Top Markets
Coin of the day
Edesa Biotech, Inc. Edesa Biotech, Inc.

Edesa Biotech, Inc.

EDSA
Classement en actions #25796
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering,... Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based in Markham, Canada.
Prix de l'action
$4.80
Dernière synchronisation: 2026-08-20
Capitalisation boursière
$46.24M
Changement (1 jour)
-16.52%
Changement (1 an)
101.68%
Pays
CA
Échange Edesa Biotech, Inc. (EDSA)

Catégorie

Historique du prix de l'action pour Edesa Biotech, Inc. (EDSA)
Prix de clôture le plus élevé : $5.37 le 2026-08-01

Prix de clôture le plus bas : $602.70 le 2010-06-01
Historique du prix de l'action de Edesa Biotech, Inc. de 2010 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 189.29%
2025 -16.90%
2024 -58.03%
2023 -48.53%
2022 -77.76%
2021 16.75%
2020 12.06%
2019 -29.49%
2018 -84.76%
2017 -54.18%
2016 -73.20%
2015 -32.44%
2014 -36.36%
2013 592.43%
2012 -41.11%
2011 -62.20%
2010 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$539.14 35.65%
US
$1.04K 56.21%
NL
$119.69 -17.56%
AU
$761.87 8.65%
CH
$130.43 397.46%
US